Clinical Trials Logo
  1. Home
  2. Acute Spinal Cord Injury
  3. NCT04475224

Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury

Acute Spinal Cord Injury Clinical Trial

Official title:
A Non-randomized, Multicenter, Confirmatory Study by Intrathecal Administration of KP-100IT in Subjects With Acute Spinal Cord Injury

Clinical Trial Summary

This study is non-randomized, multicenter, confirmatory study by intrathecal administration of KP-100IT, code of HGF (Hepatocyte Growth Factor ) formulation for intrathecal injection, in subjects with acute spinal cord injury.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04475224
Study type Interventional
Source Kringle Pharma, Inc.
Contact Etsuro Hashimura
Phone +81-72-641-8739
Email hashimura@kringle-pharma.com
Status Recruiting
Phase Phase 3
Start date July 13, 2020
Completion date June 30, 2023
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04811235 - Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial N/A
Completed NCT00406016 - Acute Safety, Tolerability, Feasibility and Pharmacokinetics of Intrath. Administered ATI355 in Patients With Acute SCI Phase 1
Recruiting NCT05305118 - TSCS for Acute SCI N/A
Recruiting NCT05244408 - "SCRIBBLE" Spinal Cord Injury Blood Biomarker Longitudinal Evaluation
Recruiting NCT05731986 - Spinal Cord Transcutaneous Stimulation Effect on Blood Pressure in Acute Spinal Cord Injury (SCI) N/A
Recruiting NCT05426681 - Spinal Cord Injury Neuroprotection With Glyburide Phase 1
Recruiting NCT04056988 - tSCI Contrast Enhanced Ultrasound Study Phase 4
Recruiting NCT05745298 - The Use of Functional Electrical Stimulation in Conjunction With Respiratory Muscle Training to Improve Unaided Cough in Individuals With Acute Spinal Cord Injury N/A
Terminated NCT01750684 - AC105 in Patients With Acute Traumatic Spinal Cord Injury Phase 2
Enrolling by invitation NCT06030531 - Spasticity and Functional Recovery After SCI
Active, not recruiting NCT03935724 - Stem Cells in Spinal Cord Injury Phase 2/Phase 3
Recruiting NCT04054414 - PMZ-1620 (Sovateltide) in Patients of Acute Spinal Cord Injury Phase 2
Recruiting NCT06000592 - Safety, Feasibility, and Efficacy of TSCS on Stabilizing Blood Pressure for Acute Inpatients With SCI N/A
Completed NCT02325414 - Prevention of Bone Loss After Acute SCI by Zoledronic Acid Phase 2
Recruiting NCT02034669 - Transplantation of Autologous Adipose Derived Stem Cells (ADSCs) in Spinal Cord Injury Treatment Phase 1/Phase 2
Terminated NCT02232165 - Mean Arterial Blood Pressure Treatment for Acute Spinal Cord Injury N/A
Completed NCT02260713 - Autologous Bone Marrow Cell Transplantation in Persons With Acute Spinal Cord Injury- An Indian Pilot Study. Phase 1/Phase 2
Terminated NCT02524379 - Spinal Cord Injury Neuroprotection With Glyburide Phase 1/Phase 2
Completed NCT01502631 - Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects With Acute Spinal Cord Injury (ASCI) Phase 2
Recruiting NCT03911492 - Canadian-American Spinal Cord Perfusion Pressure and Biomarker Study N/A